Evidence of a latent precursor (p53 signature) to uterine serous carcinoma

被引：0
|
作者：
Jarboe, E. A.
Pizer, E.
Miron, A.
Crum, C. P.
机构：
[1] Brigham & Womens Hosp, Boston, MA USA
[2] Cell Netix Pathol, Seattle, WA USA
[3] Dana Farber Canc Inst, Boston, MA USA
来源：
MODERN PATHOLOGY | 2008年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
950
引用
收藏
页码：208A / 208A
页数：1
相关论文
共 50 条
  • [31] P53 and bcl-2 assessment in serous ovarian carcinoma
    Palmer, J. E.
    Cassia, L. J. Sant
    Irwin, C. J.
    Morris, A. G.
    Rollason, T. P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (02) : 241 - 248
  • [32] Significant Overexpression of HMGAs in Serous Ovarian Carcinoma in Association with p53
    Mahajan, A.
    Gellert, L.
    Yang, X. J.
    Wei, J.
    LABORATORY INVESTIGATION, 2009, 89 : 226A - 226A
  • [33] Micropapillary serous carcinoma of the ovary: An immunohistochemical and mutational analysis of p53
    Katabuchi, H
    Tashiro, H
    Cho, KR
    Kurman, RJ
    Ellenson, LH
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1998, 17 (01) : 54 - 60
  • [34] Telomere Length in Precancerous Lesions of Ovarian Cancer Including p53 Signature and Incidental Serous Tubal Intraepithelial Carcinoma
    Asaka, Shiho
    Davis, Christine
    Lin, Shiou-Fu
    Wang, Tian-Li
    Heaphy, Christopher
    Shih, Ie-Ming
    LABORATORY INVESTIGATION, 2019, 99
  • [35] Telomere Length in Precancerous Lesions of Ovarian Cancer Including p53 Signature and Incidental Serous Tubal Intraepithelial Carcinoma
    Asaka, Shiho
    Davis, Christine
    Lin, Shiou-Fu
    Wang, Tian-Li
    Heaphy, Christopher
    Shiho, le -Ming
    MODERN PATHOLOGY, 2019, 32
  • [36] The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma -: Evidence of distinct molecular genetic pathways
    Lax, SF
    Kendall, B
    Tashiro, H
    Slebos, RJC
    Ellenson, LH
    CANCER, 2000, 88 (04) : 814 - 824
  • [37] The use of P53, PTEN, and C-erbB-2 to differentiate uterine serous papillary carcinoma from endometrioid endometrial carcinoma
    Macwhinnie, N
    Monaghan, H
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2004, 14 (05) : 938 - 946
  • [38] Null Pattern Aberrant p53 Staining is more Frequent in Uterine High-Grade Endometrioid Carcinoma Compared to Serous Carcinoma
    Ladwig, Nicholas
    Garg, Karuna
    Joehlin-Price, Amy
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1092 - 1092
  • [39] Null Pattern Aberrant p53 Staining is more Frequent in Uterine High-Grade Endometrioid Carcinoma Compared to Serous Carcinoma
    Ladwig, Nicholas
    Garg, Karuna
    Joehlin-Price, Amy
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1092 - 1092
  • [40] Precursor lesions of uterine serous carcinoma - review of the literature
    Sobczuk, Anna
    Wrona, Marcin
    Pertynski, Tomasz
    PRZEGLAD MENOPAUZALNY, 2007, 6 (06): : 376 - 380
12345